Israeli-Cleveland Collaboration Begins With Research Teams Applying Nanotechnology to Brain, Breast Cancers

Through a collaboration between Cleveland Clinic and The Hebrew University of Jerusalem, two international research teams are set to explore new treatments for cancer using nanotechnology, which utilizes science and engineering at the molecular level. Pooling expertise, scientists and physicians from Cleveland and Israel will try to determine whether tiny nanoparticles can more effectively deliver … Read More

Cleveland Clinic Cancer Researchers Find Eligibility Criteria In Clinical Trials Overly Strict

New research from Cleveland Clinic finds that clinical trials routinely use excessively strict enrollment criteria, which excludes patients who could potentially benefit from new treatments and limits trial results to a narrow group. The implications are that trials are not being designed to include participants who are representative of society, and therefore, safety results may … Read More

Dr. Cosgrove Named to President-Elect’s Strategic and Policy Forum

In a statement released Dec. 2, 2016, Toby Cosgrove, M.D., CEO and President, Cleveland Clinic, said: “I am truly honored and privileged to take part in President-elect Donald Trump’s Strategic and Policy Forum designed to grow and strengthen the United States’ economy. I applaud his efforts to bring together leaders across industries to gain insight that … Read More

Jeffrey and Patricia Cole Donate $31 Million to Cleveland Clinic Cole Eye Institute

Jeffrey A. Cole and his wife Patricia O’Brien Cole have made a transformational gift to continue their philanthropic legacy at the Cleveland Clinic Cole Eye Institute.  This $31 million commitment will help Cole Eye Institute expand its clinical and surgical capabilities as well enhance its research and educational mission.  This will be accomplished primarily through … Read More

Cleveland Clinic Researchers Find No Benefit to HDL-Raising Injection In Regression Of Coronary Heart Disease

NEW ORLEANS: Cleveland Clinic researchers have found that infusions of MDCO-216 – a drug meant to enhance high-density lipoprotein, or HDL, the so-called “good cholesterol – did not have a favorable effect on coronary disease progression. For decades it’s been suggested that HDL protects against cardiovascular disease. However, researchers have yet to show that HDL-raising agents … Read More

Cleveland Clinic-Led Study Shows Reversal of Coronary Plaque Buildup With Injectable Cholesterol Drug

NEW ORLEANS: Cleveland Clinic researchers have found that adding the injectable cholesterol-lowering drug evolocumab (Repatha) to full doses of statin drugs reversed the buildup of cholesterol plaques in the coronary artery walls after 18 months of treatment. Patients receiving the combination of evolocumab and a statin achieved an average level of LDL (“bad cholesterol”) of just … Read More

Cleveland Clinic-Led Trial of Pain-Relieving Drugs Demonstrates Cardiovascular Safety of Celecoxib

New Orleans: Cleveland Clinic researchers have found that prescription doses of widely used pain-relieving drugs demonstrated no greater heart risk for celecoxib (Celebrex) than naproxen (Naprosyn) or ibuprofen (Motrin). The decade-long PRECISION trial – Prospective Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen – enrolled more than 24,000 osteoarthritis (OA) or rheumatoid arthritis (RA) … Read More

Cleveland Clinic Avon Hospital Opens

Cleveland Clinic Avon Hospital – the first Cleveland Clinic regional hospital built in Ohio – will begin welcoming patients on Tuesday, Nov. 15. The five-story, 212,000-square-foot facility, estimated at more than $161 million, was built onto the north side of the existing Richard E. Jacobs Health Center located off Nagel Road in Avon, Ohio. The … Read More